DIRECTORS’ REMUNERATION The details of the directors’ remuneration paid or payable to the Directors of the Company during the financial year are as follows: Group RM’000 Company RM’000 Non-executive Directors - Fees 1,267 1,055 - Remuneration 217 217 Total short-term employee benefits 1,484 1,272 Executive Directors - Fees 111 – - Remuneration 3,487 3,487 - Short-term employee benefits - EPF 318 318 - Others 596 596 Total short-term employee benefits 4,512 4,401 5,996 5,673 INDEMNITY AND INSURANCE COSTS During the financial year, Directors and Officers of the Company and its subsidiaries are covered under the Directors and Officers Liability Insurance Policy (“the Policy”) in respect of liabilities arising from acts committed in their respective capacity as, inter alia, Directors and Officers of the Group subject to the terms of the Policy. The total amount of indemnity coverage and insurance premium paid for the Directors and certain Officers of the Company and of the Group were RM15,000,000 and RM21,355 respectively. ISSUE OF SHARES AND DEBENTURES During the financial year, the Company issued: i) 971,000 new ordinary shares from the exercise of options under the Company’s ESOS at the exercise price as disclosed in Note 16 to the financial statements amounting to RM1,076,000. ii) 336,021,000 new ordinary shares from conversion of warrants at the exercise price as disclosed in Note 16 to the financial statements amounting to RM185,938,000. iii) 64,577,000 new ordinary shares from private placement on 15 November 2021 at the issue price of RM0.6948 per ordinary share amounting to RM44,868,000. The new ordinary shares issued rank pari passu in all respects with the existing ordinary shares of the Company. There were no other changes in the issued and paid-up capital of the Company during the financial year. There were no debentures issued during the financial year. 193 DNeX INTEGRATED REPORT 2022
RkJQdWJsaXNoZXIy NDgzMzc=